166 related articles for article (PubMed ID: 34918488)
1. Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study.
Takamori S; Ishikawa S; Suzuki J; Oizumi H; Uchida T; Ueda S; Edamatsu K; Iino M; Sugimoto M
Thorac Cancer; 2022 Feb; 13(3):460-465. PubMed ID: 34918488
[TBL] [Abstract][Full Text] [Related]
2. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
[TBL] [Abstract][Full Text] [Related]
3. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
4. Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.
Ishikawa S; Ishizawa K; Tanaka A; Kimura H; Kitabatake K; Sugano A; Edamatsu K; Ueda S; Iino M
In Vivo; 2021; 35(1):541-547. PubMed ID: 33402507
[TBL] [Abstract][Full Text] [Related]
5. Salivary metabolomics for oral leukoplakia with and without dysplasia.
Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Salivary Metabolite Profiling on an Ultralow Noise Tip-Enhanced Laser Desorption Ionization Mass Spectrometry Platform for Noninvasive Diagnosis of Early Lung Cancer.
Jiang X; Chen X; Chen Z; Yu J; Lou H; Wu J
J Proteome Res; 2021 Sep; 20(9):4346-4356. PubMed ID: 34342461
[TBL] [Abstract][Full Text] [Related]
7. Salivary metabolites as potential predictive biomarkers for lung surgery complications: a retrospective cross-sectional study.
Takamori S; Ishikawa S; Sato K; Watanabe H; Suzuki J; Oizumi H; Shiono S; Uchida T; Okuyama N; Edamatsu K; Iino M; Sugimoto M
Surg Today; 2024 Feb; ():. PubMed ID: 38356076
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
9. Identification of salivary metabolomic biomarkers for oral cancer screening.
Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry.
Xiao H; Zhang L; Zhou H; Lee JM; Garon EB; Wong DT
Mol Cell Proteomics; 2012 Feb; 11(2):M111.012112. PubMed ID: 22096114
[TBL] [Abstract][Full Text] [Related]
11. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
12. Development of transcriptomic biomarker signature in human saliva to detect lung cancer.
Zhang L; Xiao H; Zhou H; Santiago S; Lee JM; Garon EB; Yang J; Brinkmann O; Yan X; Akin D; Chia D; Elashoff D; Park NH; Wong DTW
Cell Mol Life Sci; 2012 Oct; 69(19):3341-3350. PubMed ID: 22689099
[TBL] [Abstract][Full Text] [Related]
13. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
14. Salivary Biomarkers in Lung Cancer.
Skallevold HE; Vallenari EM; Sapkota D
Mediators Inflamm; 2021; 2021():6019791. PubMed ID: 34690552
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
16. Integrated glycomics strategy for galactosylated-N-glycans recognized by Bandeiraea Simplicifolia Lectin I in salivary proteins associated with lung cancer.
Zhang F; Xie M; Tang Z; Xie H; Yue L; Wang X; Yang J; Chen Y; Li Z
Proteomics Clin Appl; 2023 May; 17(3):e2200012. PubMed ID: 36349801
[TBL] [Abstract][Full Text] [Related]
17. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination.
Murata T; Yanagisawa T; Kurihara T; Kaneko M; Ota S; Enomoto A; Tomita M; Sugimoto M; Sunamura M; Hayashida T; Kitagawa Y; Jinno H
Breast Cancer Res Treat; 2019 Oct; 177(3):591-601. PubMed ID: 31286302
[TBL] [Abstract][Full Text] [Related]
18. Effect of masticatory stimulation on the quantity and quality of saliva and the salivary metabolomic profile.
Okuma N; Saita M; Hoshi N; Soga T; Tomita M; Sugimoto M; Kimoto K
PLoS One; 2017; 12(8):e0183109. PubMed ID: 28813487
[TBL] [Abstract][Full Text] [Related]
19. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
20. Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
Cruickshank-Quinn C; Armstrong M; Powell R; Gomez J; Elie M; Reisdorph N
Respir Res; 2017 Apr; 18(1):57. PubMed ID: 28403875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
